German university hospital whose Department of Internal Medicine III, under Hartmut Döhner, coordinates the AML Study Group and shaped the genetic classification of acute myeloid leukaemia used worldwide.
Ulm University Hospital is the academic hospital of the University of Ulm in Baden-Württemberg and hosts the Comprehensive Cancer Center Ulm. Its Department of Internal Medicine III, directed by Hartmut Döhner, is the coordinating centre of the German-Austrian AML Study Group (AMLSG) and of the European LeukemiaNet recommendations for acute myeloid leukaemia, which define the genetic risk groups used in the clinic. The department also runs trials in chronic lymphocytic leukaemia and lymphoma.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Universität Ulm, including child institutions. 249 works · 2,621 citations · 74% open access · 10% clinical trials · 2% reviews.
Shares Deutsches Netzwerk für Personalisierte Medizin, Chronic lymphocytic leukaemia, Acute myeloid leukaemia.
Shares Deutsches Netzwerk für Personalisierte Medizin, Acute myeloid leukaemia.
Shares Deutsches Netzwerk für Personalisierte Medizin, Chronic lymphocytic leukaemia.
Shares Deutsches Netzwerk für Personalisierte Medizin, Acute myeloid leukaemia.
Shares Hartmut Döhner, Acute myeloid leukaemia.